WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 13'2901 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 20'5321 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 4'307  4'324  4'338  4'350  4'360  4'475  4'794  4'401 
Births 41  41  41  41  41  44  57  68 
Surviving infants 41  41  41  41  41  44  56  67 
Pop. less than 5 years 223  224  216  213  205  241  293  333 
Pop. less than 15 years 652  661  664  673  677  768  955  951 
Female 15-49 years 967  977  989  1'001  1'014  1'097  1'165  1'136 

Number of reported case

(Click for retrospective incidence data for Croatia)
Diphtheria
Japanese encephalitis
Measles 12  51  119 
Mumps 95  86  37  56  110  152 
Pertussis 61  103  42  101  102  196  304 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 18 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Croatia)
Vaccine year result method % card seen                                                
BCG          99  99  98  99  99  98 
DTP1          97 
DTP3          96  96  97  96  96  93 
HepB_BD          96  98 
HepB3          98  97  97  97  97 
Hib3          96  97  96  96 
JapEnc         
MCV          96  96  95  98  93 
MCV2          98  98  98 
PCV1         
PCV3         
Pol3          96  97  96  96  94 
Rota1         
Rota_last         
Rubella1          95  96  96  96 
TT2plus          97 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Croatia)
BCG 99  99  98  99  99  98 
DTP1 97  97  97  97  97  95 
DTP3 96  96  97  96  96  93 
HepB3 98  97  97  97  97 
Hib3 96  96  97  96  96 
MCV 95  96  96  95  98  93 
PCV3
Pol3 96  96  97  96  96  94 
Rota_last

Number of districts in the country 21  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 95
From 80 to 89% 14
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 3 years; Yes
DTaPHibIPV 2, 4, 6 months; 1 year; Yes
HepB birth; 2, 6 months; Yes And catch up at the age of 12-13 years old
IPV 6, 13 years; Yes
MMR 1, 6 years; Yes
TT 60 years; Yes
Td 6, 13, 17 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes      Yes  Yes 
What years does the MYP cover? number   2012-2014  2010-2012        2005-2007 
Nº of districts with microplans that include activities to raise immunization coverage number           NA 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 21  113    21    21  113 
Nº districts with DTP3 coverage >=80% number 23  21        21   
% of districts with DTP3 coverage >=80% From 0 to 100% 110  19        100   
Nº districts with measles (MCV1) coverage >=95% number 16  15  17         
% of districts with MCV1 coverage >=95% From 0 to 100% 76  13           

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes      Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100        100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.